课题基金 / 基金详情

Cells and Nanobiomaterials to Treat and Prevent Pelvic Organ Prolapse

Cells and Nanobiomaterials to Treat and Prevent Pelvic Organ Prolapse
治疗和预防盆腔器官脱垂的细胞和纳米生物材料
批准号:
nhmrc : GNT1159677
负责人:
金额:
$139.73万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pelvic organ prolapse is a hidden, debilitating gynaecological disorder affecting 25% of women causing sexual, bladder and bowel dysfunction. Prolapse is the herniation of the uterus, bladder, or bowel into the vagina as a result of childbirth injury. Surgical treatment often fails and the use of vaginal mesh has been banned due to unacceptable side effects. We are developing a cell-based therapy using a woman’s own endometrial stem cells to repair the damaged tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金